Cargando…
P19: BASELINE CORRELATES OF COMPLETE RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL, BB2121), A BCMA-DIRECTED CAR T CELL THERAPY IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA: SUBANALYSIS OF THE KARMMA TRIAL
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011718/ http://dx.doi.org/10.1097/01.HS9.0000829648.85784.e2 |
| _version_ | 1784687687610925056 |
|---|---|
| author | Rodríguez-Otero, P Shah, N Munshi, N Berdeja, J Jagannath, S Finney, O Martin, N Agarwal, A Rowe, E Campbell, T San-Miguel, J |
| author_facet | Rodríguez-Otero, P Shah, N Munshi, N Berdeja, J Jagannath, S Finney, O Martin, N Agarwal, A Rowe, E Campbell, T San-Miguel, J |
| author_sort | Rodríguez-Otero, P |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9011718 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90117182022-04-18 P19: BASELINE CORRELATES OF COMPLETE RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL, BB2121), A BCMA-DIRECTED CAR T CELL THERAPY IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA: SUBANALYSIS OF THE KARMMA TRIAL Rodríguez-Otero, P Shah, N Munshi, N Berdeja, J Jagannath, S Finney, O Martin, N Agarwal, A Rowe, E Campbell, T San-Miguel, J Hemasphere Poster Lippincott Williams & Wilkins 2022-04-05 /pmc/articles/PMC9011718/ http://dx.doi.org/10.1097/01.HS9.0000829648.85784.e2 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | Poster Rodríguez-Otero, P Shah, N Munshi, N Berdeja, J Jagannath, S Finney, O Martin, N Agarwal, A Rowe, E Campbell, T San-Miguel, J P19: BASELINE CORRELATES OF COMPLETE RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL, BB2121), A BCMA-DIRECTED CAR T CELL THERAPY IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA: SUBANALYSIS OF THE KARMMA TRIAL |
| title | P19: BASELINE CORRELATES OF COMPLETE RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL, BB2121), A BCMA-DIRECTED CAR T CELL THERAPY IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA: SUBANALYSIS OF THE KARMMA TRIAL |
| title_full | P19: BASELINE CORRELATES OF COMPLETE RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL, BB2121), A BCMA-DIRECTED CAR T CELL THERAPY IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA: SUBANALYSIS OF THE KARMMA TRIAL |
| title_fullStr | P19: BASELINE CORRELATES OF COMPLETE RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL, BB2121), A BCMA-DIRECTED CAR T CELL THERAPY IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA: SUBANALYSIS OF THE KARMMA TRIAL |
| title_full_unstemmed | P19: BASELINE CORRELATES OF COMPLETE RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL, BB2121), A BCMA-DIRECTED CAR T CELL THERAPY IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA: SUBANALYSIS OF THE KARMMA TRIAL |
| title_short | P19: BASELINE CORRELATES OF COMPLETE RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL, BB2121), A BCMA-DIRECTED CAR T CELL THERAPY IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA: SUBANALYSIS OF THE KARMMA TRIAL |
| title_sort | p19: baseline correlates of complete response to idecabtagene vicleucel (ide-cel, bb2121), a bcma-directed car t cell therapy in patients with relapsed and refractory multiple myeloma: subanalysis of the karmma trial |
| topic | Poster |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011718/ http://dx.doi.org/10.1097/01.HS9.0000829648.85784.e2 |
| work_keys_str_mv | AT rodriguezoterop p19baselinecorrelatesofcompleteresponsetoidecabtagenevicleucelidecelbb2121abcmadirectedcartcelltherapyinpatientswithrelapsedandrefractorymultiplemyelomasubanalysisofthekarmmatrial AT shahn p19baselinecorrelatesofcompleteresponsetoidecabtagenevicleucelidecelbb2121abcmadirectedcartcelltherapyinpatientswithrelapsedandrefractorymultiplemyelomasubanalysisofthekarmmatrial AT munshin p19baselinecorrelatesofcompleteresponsetoidecabtagenevicleucelidecelbb2121abcmadirectedcartcelltherapyinpatientswithrelapsedandrefractorymultiplemyelomasubanalysisofthekarmmatrial AT berdejaj p19baselinecorrelatesofcompleteresponsetoidecabtagenevicleucelidecelbb2121abcmadirectedcartcelltherapyinpatientswithrelapsedandrefractorymultiplemyelomasubanalysisofthekarmmatrial AT jagannaths p19baselinecorrelatesofcompleteresponsetoidecabtagenevicleucelidecelbb2121abcmadirectedcartcelltherapyinpatientswithrelapsedandrefractorymultiplemyelomasubanalysisofthekarmmatrial AT finneyo p19baselinecorrelatesofcompleteresponsetoidecabtagenevicleucelidecelbb2121abcmadirectedcartcelltherapyinpatientswithrelapsedandrefractorymultiplemyelomasubanalysisofthekarmmatrial AT martinn p19baselinecorrelatesofcompleteresponsetoidecabtagenevicleucelidecelbb2121abcmadirectedcartcelltherapyinpatientswithrelapsedandrefractorymultiplemyelomasubanalysisofthekarmmatrial AT agarwala p19baselinecorrelatesofcompleteresponsetoidecabtagenevicleucelidecelbb2121abcmadirectedcartcelltherapyinpatientswithrelapsedandrefractorymultiplemyelomasubanalysisofthekarmmatrial AT rowee p19baselinecorrelatesofcompleteresponsetoidecabtagenevicleucelidecelbb2121abcmadirectedcartcelltherapyinpatientswithrelapsedandrefractorymultiplemyelomasubanalysisofthekarmmatrial AT campbellt p19baselinecorrelatesofcompleteresponsetoidecabtagenevicleucelidecelbb2121abcmadirectedcartcelltherapyinpatientswithrelapsedandrefractorymultiplemyelomasubanalysisofthekarmmatrial AT sanmiguelj p19baselinecorrelatesofcompleteresponsetoidecabtagenevicleucelidecelbb2121abcmadirectedcartcelltherapyinpatientswithrelapsedandrefractorymultiplemyelomasubanalysisofthekarmmatrial |